Literature DB >> 19215878

A new multiplex-PCR comprising autosomal and y-specific STRs and mitochondrial DNA to analyze highly degraded material.

Nicole von Wurmb-Schwark1, Andrea Preusse-Prange, Anke Heinrich, Eva Simeoni, Thomas Bosch, Thorsten Schwark.   

Abstract

The analysis of short tandem repeats is one of the most powerful tools in forensic genetics. Forensic practice sometimes requires the individualization of samples that may contain only highly degraded nuclear DNA, mitochondrial DNA or PCR inhibitors that hamper DNA amplification. We designed a new multiplex PCR with reduced size amplicons (<200 bp), providing a double sex determination (amelogenin plus two Y-STRs), the detection of two autosomal markers and the amplification of mitochondrial specific fragments from the hypervariable region I (HVI). Additionally, a quality sensor was developed to check for the presence of any PCR inhibitors. The new multiplex PCR shows a reproducible detection threshold down to 25 pg and gives signals even out of highly degraded materials. All signals are reproducible and reliable as it could be shown in comparison to results from commercially available STR multiplex-PCRs. In no case DNA fragments were detectable using any other assay when the quality sensor was not detectable. There was a good correlation between detection of mitochondrial specific fragments in the multiplex-PCR and success of subsequent sequencing of HVI region. The same could be shown for STR analysis: Most samples successfully analyzed in our PCR yielded at least a partial STR profile using a commercial STR kit. We present an assay that allows an easy, reliable, and cost efficient evaluation of DNA sample quality combined with a first rough sample individualization and sex determination suitable for forensic purposes. This assay may help the forensic lab personnel to decide on further sample processing.

Mesh:

Substances:

Year:  2009        PMID: 19215878     DOI: 10.1016/j.fsigen.2008.11.007

Source DB:  PubMed          Journal:  Forensic Sci Int Genet        ISSN: 1872-4973            Impact factor:   4.882


  7 in total

1.  First experiences using the new Powerplex® ESX17 and ESI17 kits in casework analysis and allele frequencies for two different regions in Germany.

Authors:  Micaela Poetsch; Katharina Bayer; Zeynep Ergin; Marco Milbrath; Thorsten Schwark; Nicole von Wurmb-Schwark
Journal:  Int J Legal Med       Date:  2010-06-22       Impact factor: 2.686

2.  DNA survival and physical and histological properties of heat-induced alterations in burnt bones.

Authors:  K Imaizumi; K Taniguchi; Y Ogawa
Journal:  Int J Legal Med       Date:  2014-05       Impact factor: 2.686

3.  Association of TH01 with human longevity revisited.

Authors:  Nicole von Wurmb-Schwark; Amke Caliebe; Thorsten Schwark; Rabea Kleindorp; Micaela Poetsch; Stefan Schreiber; Almut Nebel
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

4.  DNA and RNA analysis of blood and muscle from bodies with variable postmortem intervals.

Authors:  Jakob Hansen; Iana Lesnikova; Anette Mariane Daa Funder; Jytte Banner
Journal:  Forensic Sci Med Pathol       Date:  2014-06-10       Impact factor: 2.007

5.  Does zero really mean nothing?-first experiences with the new PowerQuant(TM) system in comparison to established real-time quantification kits.

Authors:  Micaela Poetsch; Helen Konrad; Janine Helmus; Thomas Bajanowski; Nicole von Wurmb-Schwark
Journal:  Int J Legal Med       Date:  2016-03-14       Impact factor: 2.686

6.  STR-typing of ancient skeletal remains: which multiplex-PCR kit is the best?

Authors:  Melanie Harder; Rebecca Renneberg; Patrick Meyer; Ben Krause-Kyora; Nicole von Wurmb-Schwark
Journal:  Croat Med J       Date:  2012-10       Impact factor: 1.351

7.  Forensic STR profiling based smart barcode, a highly efficient and cost effective human identification system.

Authors:  Andleeb Zahra; Bilal Hussain; Amer Jamil; Z Ahmed; Shahid Mahboob
Journal:  Saudi J Biol Sci       Date:  2018-10-02       Impact factor: 4.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.